Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 7.2.2023Recordati Ireland Limited (REC-2)6515BVitaros 3 mg/g krém (crm 4x100 mg (aplikátor AccuDose))7.2.2023Z
 7.2.2023Pfizer Europe MA EEIG (PFI-BE-3)72568UNASYN P.O.S. 250 mg/5 ml (plu por 1x60 ml (fľ.HDPE))8.11.2022R
 7.2.2023Pfizer Europe MA EEIG (PFI-BE-3)72568UNASYN P.O.S. 250 mg/5 ml (plu por 1x60 ml (fľ.HDPE))7.11.2022O
 7.2.2023B.Braun Melsungen AG (BME)2917AKaliumchlorid/natriumchlorid 0,3 % + 0,9 % B. Braun (sol inf 10x500 ml (fľ.PE))7.2.2023R
 7.2.2023B.Braun Melsungen AG (BME)2913AKaliumchlorid/glucose 0,3 % + 5 % B. Braun (sol inf 10x500 ml (fľ.PE))7.2.2023R
 7.2.2023CHEPLAPHARM Arzneimittel GmbH (CEP-1)36915Duomox 1000 (tbl dsp 14x1000 mg (blis.PVC/Al))1.11.2022Z
 7.2.2023CHEPLAPHARM Arzneimittel GmbH (CEP-1)62052Duomox 1000 (tbl dsp 20x1000 mg (blis.PVC/Al))1.11.2022Z
 7.2.2023BB Pharma a.s. (BBP-CZ-1)6118ACeftron 1 g (plo ijf 1x1 g (fľ.skl.))2.1.2023R
 6.2.2023Viatris Limited (VIM)92955Zolpidem Viatris 10 mg (tbl flm 20x10 mg (blister PVC/Al))6.2.2023O
 6.2.2023Takeda GmbH (TKD-3)34803CONTROLOC i.v. (plv ino 5x40 mg (liek.skl.))7.2.2023O
 6.2.2023GlaxoSmithKline (Ireland) Limited (GAG-IE-2)96535Imigran (sol inj 2x0,5 ml/6 mg (striek.inj.napl.+autoinjektor))25.1.2023R
 6.2.2023Gedeon Richter Plc. (GDN)1273EJUZIMETTE 50 mg/1000 mg filmom obalené tablety (tbl flm 56x50mg/1000 mg (blis.PVC/PE/PVDC//Al))6.2.2023U
 6.2.2023CHEPLAPHARM Arzneimittel GmbH (CEP-1)89771Ebrantil 60 (cps pld 50x60 mg (fľ.HDPE))16.11.2022R
 6.2.2023CHEPLAPHARM Arzneimittel GmbH (CEP-1)90760Ebrantil 30 (cps pld 50x30 mg (fľ.HDPE))16.11.2022R
 5.2.2023Desitin Arzneimitttel GmbH (DET)69417Diazepam Desitin rectal tube 5 mg (sol rec 5x2,5 ml/5 mg (tuba PE))6.2.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To